The college football season is winding down, with just three games until a national champion is crowned. On Thursday, January ...

Nvidia may not have announced any new graphics cards at CES 2026, but it did reveal two stunning technology upgrades: ...

Cinema 4D is a professional solution for motion graphics, animation, rendering, modeling, and VFX on macOS, trusted by designers, studios, and filmmakers worldwide. Maxon Cinema 4D is a leading 3D ...

Bubsy 4D has taken me by surprise. Though I grew up gaming through the '90s and playing a lot of platformers, this bobcat never grabbed me, his maligned jump into 3D doing him no favors. Which is why ...

The washed-up platforming mascot is back. Again. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Add us as a preferred source on Google Polite ...

Even with powerful laptops and tablets at our fingertips, desktop computers still hold their own, especially when it’s time to focus. A larger screen doesn’t just mean a bigger picture; it can make ...

On the first day of the Hungry Ghost Month last Saturday (Aug 23), a group of devotees in Sembawang struck it big after betting on a 'lucky' 4D number posted at the prayer altar. The 'lucky' number ...

On Windows 11/10, the User Account/Profile at the location %SystemDrive%\Users\<UserName> contains files, folders, and data that the associated user can access easily ...

Publisher Atari and developer Fabraz have announced Bubsy 4D for PlayStation 5, Xbox Series, Switch 2, PlayStation 4, Xbox One, Switch, and PC (Steam, Epic Games Store, GOG). A release date was not ...

Bubsy the Bobcat, star of the eponymous, oft-derided Bubsy series of hit-or-miss platforming games, is back in a new adventure called Bubsy 4D. Publisher Atari and developer Fabraz, known for the ...

Atari has announced a brand-new Bubsy game – no, really! In collaboration with developer Fabraz, known for the rather excellent Demon Turf, Bubsy 4D will launch on the Switch and Switch 2. And it ...

4D Molecular Therapeutics laid off a quarter of its workforce last month with early-stage R&D bearing the brunt of the changes. The genetic medicines biotech said shrinking its headcount by 25% should ...